LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
JSPR Jasper Therapeutics
- 5.930
- +0.260+4.59%
Close Feb 28 16:00 ET
- 6.000
- +0.070+1.18%
Post 20:01 ET
88.96MMarket Cap-1.21P/E (TTM)
6.010High5.565Low329.49KVolume5.690Open5.670Pre Close1.94MTurnover3.33%Turnover RatioLossP/E (Static)15.00MShares31.01052wk High1.44P/B58.63MFloat Cap4.55052wk Low--Dividend TTM9.89MShs Float188.800Historical High--Div YieldTTM7.85%Amplitude3.862Historical Low5.881Avg Price1Lot Size
Jasper Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -17.55%71.64M | -17.55%71.64M | -10.94%92.5M | -7.77%106.82M | -8.44%118.48M | 127.16%86.89M | 127.16%86.89M | 103.86%103.87M | 90.44%115.81M | 83.81%129.4M |
| -Cash and cash equivalents | -17.55%71.64M | -17.55%71.64M | -10.94%92.5M | -7.77%106.82M | -8.44%118.48M | 127.16%86.89M | 127.16%86.89M | 103.86%103.87M | 90.44%115.81M | 83.81%129.4M |
| Receivables | ---- | ---- | -6.72%250K | -24.24%250K | 0.00%250K | -72.62%250K | -72.62%250K | -30.21%268K | -25.51%330K | -55.60%250K |
| -Taxes receivable | ---- | ---- | 0.00%250K | -9.75%250K | 0.00%250K | 0.00%250K | 0.00%250K | -6.37%250K | -30.23%277K | -54.38%250K |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -84.62%18K | 15.22%53K | ---- |
| Prepaid assets | ---- | ---- | 112.65%1.43M | -35.89%1.14M | -38.78%1.14M | -32.30%1.49M | -32.30%1.49M | -37.60%672K | -11.49%1.77M | -33.54%1.87M |
| Other current assets | 1,250.81%4.17M | 1,250.81%4.17M | 52.07%625K | -27.26%475K | -55.60%440K | -15.11%309K | -15.11%309K | --411K | 2,318.52%653K | 3,570.37%991K |
| Total current assets | -14.76%75.81M | -14.76%75.81M | -9.90%94.81M | -8.34%108.68M | -9.21%120.31M | 113.12%88.94M | 113.12%88.94M | 100.76%105.22M | 87.35%118.57M | 79.55%132.51M |
| Non current assets | ||||||||||
| Net PPE | -32.02%2.85M | -32.02%2.85M | -27.12%3.18M | -22.61%3.67M | -25.30%3.82M | -23.10%4.19M | -23.10%4.19M | -24.05%4.36M | -22.10%4.74M | -10.73%5.11M |
| -Gross PPE | -57.15%2.85M | -57.15%2.85M | 3.50%6.77M | 1.11%6.72M | -2.52%6.56M | -2.23%6.65M | -2.23%6.65M | -4.14%6.54M | -3.70%6.64M | 6.64%6.73M |
| -Accumulated depreciation | ---- | ---- | -64.81%-3.59M | -60.28%-3.05M | -69.00%-2.75M | -81.95%-2.46M | -81.95%-2.46M | -101.76%-2.18M | -134.40%-1.9M | -174.20%-1.63M |
| Other non current assets | -29.72%1.24M | -29.72%1.24M | 72.71%1.43M | 83.29%1.58M | 61.12%1.84M | 49.66%1.76M | 49.66%1.76M | -13.75%828K | -13.28%862K | 11.09%1.14M |
| Total non current assets | -31.34%4.09M | -31.34%4.09M | -11.18%4.61M | -6.32%5.25M | -9.51%5.66M | -10.20%5.95M | -10.20%5.95M | -22.57%5.19M | -20.86%5.6M | -7.41%6.25M |
| Total assets | -15.80%79.9M | -15.80%79.9M | -9.96%99.41M | -8.25%113.93M | -9.22%125.96M | 96.22%94.89M | 96.22%94.89M | 86.78%110.41M | 76.46%124.17M | 72.27%138.76M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -2.94%4.03M | -2.94%4.03M | -5.22%3.09M | 87.48%2.96M | -37.83%2.39M | 134.67%4.15M | 134.67%4.15M | 4.46%3.26M | -47.25%1.58M | 144.81%3.85M |
| -accounts payable | -2.94%4.03M | -2.94%4.03M | -5.22%3.09M | 87.48%2.96M | -37.83%2.39M | 134.67%4.15M | 134.67%4.15M | 4.46%3.26M | -47.25%1.58M | 162.35%3.85M |
| Current accrued expenses | 95.80%10.12M | 95.80%10.12M | -16.81%4.89M | -22.47%4M | 90.89%4.25M | 94.98%5.17M | 94.98%5.17M | 311.40%5.88M | 227.22%5.16M | -19.86%2.23M |
| Current debt and capital lease obligation | 12.04%1.09M | 12.04%1.09M | 12.06%1.06M | 12.21%1.03M | 12.23%1M | 12.37%972K | 12.37%972K | 12.50%945K | 16.96%917K | 71.02%891K |
| -Current capital lease obligation | 12.04%1.09M | 12.04%1.09M | 12.06%1.06M | 12.21%1.03M | 12.23%1M | 12.37%972K | 12.37%972K | 12.50%945K | 16.96%917K | 71.02%891K |
| Other current liabilities | ---- | ---- | 102.14%849K | 20.05%467K | 17.61%501K | 63.40%317K | 63.40%317K | -48.53%420K | -25.05%389K | -43.05%426K |
| Current liabilities | 23.14%15.24M | 23.14%15.24M | 4.64%12.46M | 12.22%10.07M | 12.98%8.92M | 75.15%12.37M | 75.15%12.37M | 60.44%11.91M | 35.49%8.97M | 32.22%7.89M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -60.09%724K | -60.09%724K | -51.18%1.01M | -44.45%1.29M | -39.19%1.55M | -34.89%1.81M | -34.89%1.81M | -31.35%2.07M | -28.35%2.32M | -24.50%2.55M |
| -Long term capital lease obligation | -60.09%724K | -60.09%724K | -51.18%1.01M | -44.45%1.29M | -39.19%1.55M | -34.89%1.81M | -34.89%1.81M | -31.35%2.07M | -28.35%2.32M | -24.50%2.55M |
| Employee benefits | ---- | ---- | ---- | ---- | ---- | --0 | --0 | -99.07%1K | ---- | ---- |
| Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Other non current liabilities | 0.00%2.26M | 0.00%2.26M | -1.39%2.26M | -15.40%2.26M | -27.27%2.26M | -4.15%2.26M | -4.15%2.26M | 282.67%2.3M | 346.00%2.68M | 418.83%3.11M |
| Total non current liabilities | -26.73%2.99M | -26.73%2.99M | -25.01%3.27M | -28.88%3.55M | -32.65%3.82M | -23.16%4.08M | -23.16%4.08M | 5.87%4.37M | 0.60%4.99M | -12.47%5.67M |
| Total liabilities | 10.78%18.23M | 10.78%18.23M | -3.31%15.73M | -2.48%13.62M | -6.09%12.73M | 32.98%16.45M | 32.98%16.45M | 40.94%16.27M | 20.54%13.97M | 8.97%13.56M |
| Shareholders'equity | ||||||||||
| Share capital | 100.00%2K | 100.00%2K | -81.82%2K | -81.82%2K | -81.82%2K | --1K | --1K | 175.00%11K | 175.00%11K | 175.00%11K |
| -common stock | 100.00%2K | 100.00%2K | -81.82%2K | -81.82%2K | -81.82%2K | --1K | --1K | 175.00%11K | 175.00%11K | 175.00%11K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -42.02%-240.87M | -42.02%-240.87M | -41.52%-216.55M | -46.09%-197.91M | -53.55%-183.33M | -61.32%-169.6M | -61.32%-169.6M | -66.46%-153.02M | -69.21%-135.48M | -71.40%-119.4M |
| Paid-in capital | 21.97%302.54M | 21.97%302.54M | 21.48%300.23M | 21.39%298.22M | 21.25%296.56M | 75.76%248.04M | 75.76%248.04M | 77.18%247.14M | 76.95%245.67M | 77.54%244.58M |
| Total stockholders'equity | -21.37%61.67M | -21.37%61.67M | -11.10%83.68M | -8.98%100.31M | -9.56%113.23M | 117.96%78.44M | 117.96%78.44M | 97.90%94.13M | 87.48%110.21M | 83.83%125.2M |
| Total equity | -21.37%61.67M | -21.37%61.67M | -11.10%83.68M | -8.98%100.31M | -9.56%113.23M | 117.96%78.44M | 117.96%78.44M | 97.90%94.13M | 87.48%110.21M | 83.83%125.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025